Evidence map›Paper›PMID 30787321›Full record

ArticleNature communications2019

Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy.

Heidi M Haikala, Johanna M Anttila, Elsa Marques, Tiina Raatikainen, Mette Ilander, Henna Hakanen, Hanna Ala-Hongisto, Mariel Savelius, Diego Balboa, Bjoern Von Eyss and 17 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 3 countries.

Heidi M HaikalaCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8465-8568
Johanna M AnttilaCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Elsa MarquesCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Tiina RaatikainenCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Mette IlanderHematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
Henna HakanenHematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
Hanna Ala-HongistoCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Mariel SaveliusCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Diego BalboaResearch Programs Unit/Molecular Neurology, Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0002-4784-5452
Bjoern Von EyssLeibniz Institute of Age Research, Fritz Lipmann Institute e.V, Beutenbergstraße 11, 07745, Jena, Germany.ORCID http://orcid.org/0000-0002-4731-6841
Vilja EskelinenCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Pauliina MunneCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.
Anni I NieminenDepartment of Biosciences and Institute of Biotechnology, University of Helsinki, Viikinkaari 5, 00790, Helsinki, Finland.
Timo OtonkoskiResearch Programs Unit/Molecular Neurology, Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0001-9190-2496
Julia SchülerOncotest GmbH, (Now part of Charles River Laboratories Inc, 251 Ballardvale St, Wilmington, MA 01887, USA), Freiburg, Germany.
Teemu D LaajalaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Tukholmankatu 3, 00290, Helsinki, Finland.
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Tukholmankatu 3, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0002-0886-9769
Harri SihtoResearch Programs Unit / Translational Cancer Biology & Medicum, University of Helsinki, P.O. Box 63, (Street address: Haartmaninkatu 8), 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0001-5265-5509
Johanna MattsonDepartment of Oncology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland.
Päivi HeikkiläDepartment of Pathology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 3, 00290, Helsinki, Finland.
Marjut LeideniusBreast Surgery Unit, Helsinki University Hospital, Kasarmikatu 11-13, 00290, Helsinki, Finland.
Heikki JoensuuResearch Programs Unit / Translational Cancer Biology & Medicum, University of Helsinki, P.O. Box 63, (Street address: Haartmaninkatu 8), 00290, Helsinki, Finland.
Satu MustjokiHematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0002-0816-8241
Panu KovanenDepartment of Pathology, HUSLAB and Haartman Institute, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 3, 00290, Helsinki, Finland.
Martin EilersTheodor Boveri Institute and Comprehensive Cancer Center Mainfranken, Biocenter, University of Würzburg, Am Hubland, D-970074, Germany.ORCID http://orcid.org/0000-0002-0376-6533
Joel D LeversonOncology Development, AbbVie, Inc., 1 N Waukegan Road, North Chicago, 60064, IL, USA.
Juha KlefströmCancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland. Juha.Klefstrom@helsinki.fi.
University of Helsinki · FIAbbVie (United States) · USCharles River Laboratories (Germany) · DEHelsinki University Hospital · FILeibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this Article contained an error in Fig. 7. In panel b, the survival curves were shifted relative to the y axis. This error has been corrected in both the PDF and HTML versions of the Article.

Identifiers

PMID30787321
PMCPMC6382943
OpenAlexW2915321387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.